Northern Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-764,310
Closed -$15.4M 4808
2021
Q3
$15.4M Sell
764,310
-11,349
-1% -$229K ﹤0.01% 1972
2021
Q2
$28.9M Buy
775,659
+4,190
+0.5% +$156K 0.01% 1623
2021
Q1
$19.7M Sell
771,469
-62,427
-7% -$1.6M ﹤0.01% 1833
2020
Q4
$18.4M Sell
833,896
-15,966
-2% -$352K ﹤0.01% 1848
2020
Q3
$15.3M Sell
849,862
-34,744
-4% -$625K ﹤0.01% 1823
2020
Q2
$22.5M Buy
884,606
+165,013
+23% +$4.19M 0.01% 1517
2020
Q1
$13.2M Buy
719,593
+32,342
+5% +$594K ﹤0.01% 1703
2019
Q4
$15.1M Sell
687,251
-191
-0% -$4.21K ﹤0.01% 1919
2019
Q3
$9.87M Buy
687,442
+3,760
+0.5% +$54K ﹤0.01% 2147
2019
Q2
$10.8M Buy
683,682
+24,348
+4% +$383K ﹤0.01% 2106
2019
Q1
$9.66M Buy
659,334
+12,191
+2% +$179K ﹤0.01% 2168
2018
Q4
$6.92M Buy
647,143
+88,559
+16% +$947K ﹤0.01% 2307
2018
Q3
$8.52M Buy
558,584
+71,916
+15% +$1.1M ﹤0.01% 2351
2018
Q2
$5.96M Buy
486,668
+427,284
+720% +$5.23M ﹤0.01% 2595
2018
Q1
$568K Buy
59,384
+23,102
+64% +$221K ﹤0.01% 3531
2017
Q4
$327K Buy
36,282
+272
+0.8% +$2.45K ﹤0.01% 3663
2017
Q3
$207K Sell
36,010
-209
-0.6% -$1.2K ﹤0.01% 3792
2017
Q2
$114K Buy
36,219
+2,094
+6% +$6.59K ﹤0.01% 3945
2017
Q1
$116K Buy
34,125
+1,274
+4% +$4.33K ﹤0.01% 3925
2016
Q4
$94K Sell
32,851
-10,761
-25% -$30.8K ﹤0.01% 3916
2016
Q3
$257K Buy
43,612
+7,149
+20% +$42.1K ﹤0.01% 3666
2016
Q2
$109K Sell
36,463
-140,182
-79% -$419K ﹤0.01% 3871
2016
Q1
$946K Buy
176,645
+6,177
+4% +$33.1K ﹤0.01% 3275
2015
Q4
$2.02M Sell
170,468
-291
-0.2% -$3.45K ﹤0.01% 3060
2015
Q3
$1.4M Buy
170,759
+97,779
+134% +$803K ﹤0.01% 3218
2015
Q2
$1.02M Buy
72,980
+20,143
+38% +$281K ﹤0.01% 3335
2015
Q1
$1.27M Buy
52,837
+4,332
+9% +$104K ﹤0.01% 3327
2014
Q4
$799K Buy
48,505
+2,197
+5% +$36.2K ﹤0.01% 3446
2014
Q3
$590K Buy
46,308
+4,618
+11% +$58.8K ﹤0.01% 3532
2014
Q2
$941K Buy
41,690
+21,967
+111% +$496K ﹤0.01% 3416
2014
Q1
$557K Buy
+19,723
New +$557K ﹤0.01% 3527